ALFA Filings
Every announcement, straight from the exchange
Every Anupam Rasayan India acquisition announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements
Anupam Rasayan corrected its previous disclosure regarding the acquisition of Bliss GVS Pharma Limited, clarifying the share counts acquired by the company and its PAC.
Anupam Rasayan's subsidiary, Mates Visa Consultancy, will acquire a 47.95% stake in Bliss GVS Pharma Limited for ₹1,524.44 Crore to strengthen its pharmaceutical value chain.
Anupam Rasayan India Ltd acquired 22,50,000 shares of Bliss GVS Pharma Limited for ₹162.74 Crore, gaining control and being designated as its promoter.
Anupam Rasayan has completed the acquisition of a 48.2% controlling stake in Bliss GVS Pharma. The transaction was funded through Rs.1,750 Crore in capital.
Anupam Rasayan India Ltd. acquired 2,60,065 shares in Tanfac Industries Ltd. for ₹60.88 Crore via a preferential issue to increase its stake in the subsidiary.
Anupam Rasayan will acquire a controlling 43.30% stake in Bliss GVS Pharma for ₹1369.51 Crore. This strategic acquisition integrates pharmaceutical operations and unlocks operational synergies.
Anupam Rasayan announced a ₹300 Crore acquisition of a 43.3-48.2% stake in Bliss GVS Pharma Limited. The deal integrates its specialty chemical capabilities with pharmaceutical formulations.
Anupam Rasayan will acquire up to 74.20% of Bliss GVS Pharma for approximately ₹2250.36 Crore. This strategic acquisition strengthens the company's presence across the pharmaceutical value chain.